The TOPRA Summit provides the chance to hear from regulators about the current state of the International Recognition Procedure as a path to accelerate approval of innovative medicines in multiple markets, as they work together to enable faster approvals.
Market access leaders share the key parameters which regulatory affairs professionals should consider for the subsequent rapid access of such medicines. An industry leader will also reveal the key success factors for accelerating approvals, working alongside the regulatory and access stakeholder network, and examine what a ‘good regulatory system’ looks like.
The Summit is an opportunity to not only hear about the current status of this evolving system for product approval, but also to discuss challenges and opportunities and share ideas about how to evolve the future framework in this multi-stakeholder forum for leading regulatory affairs professionals.
Watch our video below to see what our event was like in London, UK earlier this year.
Supported by 